PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796095
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796095
Global Bare-Metal Stents Market to Reach US$5.1 Billion by 2030
The global market for Bare-Metal Stents estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Self-Expandable Stent, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Balloon Expandable Stent segment is estimated at 3.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 8.3% CAGR
The Bare-Metal Stents market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Global Bare-Metal Stents Market - Key Trends & Drivers Summarized
How Are Clinical Preferences and Treatment Accessibility Sustaining the Relevance of Bare-Metal Stents?
Despite the rapid advancement and adoption of drug-eluting stents, bare-metal stents continue to maintain a significant presence in interventional cardiology due to their specific clinical advantages and broader accessibility. Bare-metal stents, made primarily from stainless steel or cobalt-chromium alloys, are favored in cases where patients are unable to adhere to prolonged dual antiplatelet therapy, which is commonly required for drug-eluting stents. These stents allow for a shorter duration of post-procedure medication, making them suitable for elderly patients, individuals with bleeding risks, or those requiring urgent surgery shortly after stent placement. Additionally, bare-metal stents are often used in low-resource settings where cost is a critical consideration, as they are significantly less expensive than their drug-eluting counterparts. In many developing countries, public health systems and smaller clinics rely on these devices due to budget constraints, reinforcing their ongoing relevance. Furthermore, bare-metal stents have a long track record of safety, rapid endothelialization, and mechanical durability, which are valuable attributes in specific patient populations. As a result, interventional cardiologists continue to incorporate them into treatment plans where their unique benefits align with patient needs, reinforcing their role in a diverse range of clinical scenarios.
Why Are Material Advancements and Design Improvements Enhancing Bare-Metal Stent Performance?
Technological progress in metallurgy and engineering has significantly improved the performance and clinical outcomes of bare-metal stents in recent years. Modern stents are now manufactured using high-strength alloys such as cobalt-chromium and platinum-chromium, which provide better radial strength and radiopacity while allowing for thinner struts. Thinner struts contribute to faster endothelial healing and lower risk of restenosis, without compromising mechanical integrity. Additionally, advances in laser cutting and surface finishing technologies have enhanced the precision of stent architecture, resulting in better flexibility, conformability, and ease of deployment within tortuous vessels. Surface modifications and coatings are also being developed to reduce thrombogenicity and enhance biocompatibility, even in the absence of pharmacological coatings. Computational modeling and imaging-guided design processes have enabled the optimization of cell geometry to ensure consistent expansion, reduced arterial wall stress, and minimal recoil. These innovations are helping bare-metal stents deliver improved clinical outcomes while maintaining the advantages of lower cost and simpler post-procedure management. While they may not match the long-term restenosis prevention of drug-eluting stents in all cases, these advancements are narrowing the performance gap and offering a more refined treatment option for specific patient cohorts.
How Do Health System Constraints and Global Market Dynamics Influence Bare-Metal Stent Utilization?
The utilization of bare-metal stents across global healthcare systems is shaped by a complex interplay of economic, demographic, and policy factors. In many emerging economies, healthcare infrastructure is under strain due to increasing patient loads, limited budgets, and variable access to advanced medical technologies. In such environments, bare-metal stents remain a vital and cost-effective tool in the treatment of coronary artery disease. They are widely used in government-sponsored health programs, non-profit hospitals, and rural health facilities where affordability and immediate availability often outweigh long-term therapeutic optimization. Insurance coverage policies and reimbursement structures also influence stent selection, particularly in countries where public health funding does not cover high-cost interventions like drug-eluting stents. Additionally, the increasing prevalence of cardiovascular diseases in aging populations and low-income communities contributes to sustained demand for low-cost stenting solutions. In emergency procedures where rapid intervention is needed and the patient’s medication history or risk profile is unknown, clinicians may prefer bare-metal stents due to their simpler antiplatelet therapy requirements. Furthermore, ongoing clinical research and registry data collection are providing new insights into patient-specific outcomes, helping physicians make evidence-based choices that include bare-metal options in certain cases. These global market dynamics ensure that bare-metal stents remain relevant, particularly where clinical pragmatism intersects with economic realities.
What Is Driving the Growth of the Global Bare-Metal Stents Market?
The growth in the global bare-metal stents market is driven by a variety of interrelated clinical, economic, and technological factors. One of the key drivers is the continued need for affordable cardiovascular interventions in low- and middle-income countries where access to premium medical devices is still limited. Bare-metal stents offer a practical and cost-effective solution for healthcare systems aiming to expand the reach of interventional cardiology. Another major growth factor is the aging global population, which is increasing the incidence of coronary artery disease and the need for less invasive, rapidly deployable treatments. Bare-metal stents are often used in high-risk patients or those requiring non-cardiac surgery shortly after angioplasty, situations where short-duration antiplatelet therapy is advantageous. The increasing awareness of cardiovascular health and the expansion of diagnostic capabilities in previously underserved regions are also contributing to a broader base of patients eligible for stenting procedures. Technological refinements in stent design, along with improvements in delivery systems and procedural efficiency, are enhancing their clinical appeal. Additionally, favorable regulatory policies in certain markets and a well-established manufacturing and distribution network continue to support steady supply and adoption. As healthcare providers strive to balance clinical efficacy with cost control, the demand for bare-metal stents is expected to persist, especially in diverse and rapidly growing markets around the world.
SCOPE OF STUDY:
The report analyzes the Bare-Metal Stents market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Self-Expandable Stent, Balloon Expandable Stent); Material (Stainless Steel Material, Cobalt-Chromium Alloy Material, Other Materials); End-User (Hospitals End-User, Specialized Clinics / Centers End-User, Ambulatory Surgery Centers End-User)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 48 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.